NCT02360579 · BASELINE
Baseline characteristics
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- denoms
- counts
- group Id
- BG000
- value
- 23
- group Id
- BG001
- value
- 67
- group Id
- BG002
- value
- 12
- group Id
- BG003
- value
- 89
- group Id
- BG004
- value
- 191
- units
- Participants
- groups
- description
- Non-cryopreserved LN-144 (Gen 1 infusion product) (Closed)
- id
- BG000
- title
- Cohort 1
- description
- Cryopreserved lifileucel (LN-144) (Gen 2 infusion product) (Closed)
- id
- BG001
- title
- Cohort 2
- description
- Retreatment cohort: patients from Cohort 1, Cohort 2 or Cohort 4 may rescreen for a second TIL regimen therapy if they meet all Inclusion and Exclusion Criteria (except exclusion criterion b) (Closed)
- id
- BG002
- title
- Cohort 3
- description
- Cryopreserved lifileucel (LN-144) (Gen 2 infusion product) (Closed)
- id
- BG003
- title
- Cohort 4
- description
- Total of all reporting groups
- id
- BG004
- title
- Total
- measures
- calculate Pct
- false
- classes
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 0
- title
- <=18 years
- measurements
- group Id
- BG000
- value
- 21
- group Id
- BG001
- value
- 53
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 66
- group Id
- BG004
- value
- 140
- title
- Between 18 and 65 years
- measurements
- group Id
- BG000
- value
- 2
- group Id
- BG001
- value
- 14
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 23
- group Id
- BG004
- value
- 39
- title
- >=65 years
- denoms
- counts
- group Id
- BG000
- value
- 23
- group Id
- BG001
- value
- 67
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 89
- group Id
- BG004
- value
- 179
- units
- Participants
- title
- Initial Treatment
- categories
- measurements
- group Id
- BG002
- value
- 0
- group Id
- BG004
- value
- 0
- title
- <=18 years
- measurements
- group Id
- BG002
- value
- 11
- group Id
- BG004
- value
- 11
- title
- Between 18 and 65 years
- measurements
- group Id
- BG002
- value
- 1
- group Id
- BG004
- value
- 1
- title
- >=65 years
- denoms
- counts
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 12
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 12
- units
- Participants
- title
- Retreatment
- param Type
- COUNT_OF_PARTICIPANTS
- population Description
- Cohort 3 patients had progressed following initial treatment in Cohorts 1, 2, 4 and then were retreated with a second TIL regimen. Data prior to initial TIL treatment are presented in the retreatment period for Cohort 3
- title
- Age, Categorical
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- lower Limit
- 37
- upper Limit
- 72
- value
- 52
- group Id
- BG001
- lower Limit
- 20
- upper Limit
- 79
- value
- 55
- group Id
- BG003
- lower Limit
- 25
- upper Limit
- 74
- value
- 58
- group Id
- BG004
- lower Limit
- 20
- upper Limit
- 79
- value
- 56
- denoms
- counts
- group Id
- BG000
- value
- 23
- group Id
- BG001
- value
- 67
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 89
- group Id
- BG004
- value
- 179
- units
- Participants
- title
- Initial Treatment
- categories
- measurements
- group Id
- BG002
- lower Limit
- 29
- upper Limit
- 66
- value
- 52
- group Id
- BG004
- lower Limit
- 29
- upper Limit
- 66
- value
- 52
- denoms
- counts
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 12
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 12
- units
- Participants
- title
- Retreatment
- dispersion Type
- FULL_RANGE
- param Type
- MEDIAN
- population Description
- Cohort 3 patients had progressed following initial treatment in Cohorts 1, 2, 4 and then were retreated with a second TIL regimen. Data prior to initial TIL treatment are presented in the retreatment period for Cohort 3
- title
- Age, Continuous
- unit Of Measure
- Years
- calculate Pct
- false
- classes
- categories
- measurements
- group Id
- BG000
- value
- 12
- group Id
- BG001
- value
- 28
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 44
- group Id
- BG004
- value
- 84
- title
- Female
- measurements
- group Id
- BG000
- value
- 11
- group Id
- BG001
- value
- 39
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 45
- group Id
- BG004
- value
- 95
- title
- Male
- denoms
- counts
- group Id
- BG000
- value
- 23
- group Id
- BG001
- value
- 67
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 89
- group Id
- BG004
- value
- 179
- units
- Participants
- title
- Initial Treatment
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 3
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 3
- title
- Female
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 9
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 9
- title
- Male
- denoms
- counts
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 12
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 12
- units
- Participants
- title
- Retreatment
- param Type
- COUNT_OF_PARTICIPANTS
- population Description
- Cohort 3 patients had progressed following initial treatment in Cohorts 1, 2, 4 and then were retreated with a second TIL regimen. Data prior to initial TIL treatment are presented in the retreatment period for Cohort 3
- title
- Sex: Female, Male
- unit Of Measure
- Participants
- calculate Pct
- false
- classes
- categories
- measurements
- group Id
- BG000
- value
- 2
- group Id
- BG001
- value
- 5
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 3
- group Id
- BG004
- value
- 10
- title
- Hispanic or Latino
- measurements
- group Id
- BG000
- value
- 21
- group Id
- BG001
- value
- 55
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 85
- group Id
- BG004
- value
- 161
- title
- Not Hispanic or Latino
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 7
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 1
- group Id
- BG004
- value
- 8
- title
- Unknown or Not Reported
- denoms
- counts
- group Id
- BG000
- value
- 23
- group Id
- BG001
- value
- 67
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 89
- group Id
- BG004
- value
- 179
- units
- Participants
- title
- Initial Treatment
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 1
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 1
- title
- Hispanic or Latino
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 10
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 10
- title
- Not Hispanic or Latino
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 1
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 1
- title
- Unknown or Not Reported
- denoms
- counts
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 12
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 12
- units
- Participants
- title
- Retreatment
- param Type
- COUNT_OF_PARTICIPANTS
- population Description
- Cohort 3 patients had progressed following initial treatment in Cohorts 1, 2, 4 and then were retreated with a second TIL regimen. Data prior to initial TIL treatment are presented in the retreatment period for Cohort 3
- title
- Ethnicity (NIH/OMB)
- unit Of Measure
- Participants
- calculate Pct
- false
- classes
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 0
- title
- American Indian or Alaska Native
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 2
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 1
- group Id
- BG004
- value
- 3
- title
- Asian
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 0
- title
- Native Hawaiian or Other Pacific Islander
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 1
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 2
- group Id
- BG004
- value
- 3
- title
- Black or African American
- measurements
- group Id
- BG000
- value
- 23
- group Id
- BG001
- value
- 64
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 85
- group Id
- BG004
- value
- 172
- title
- White
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 0
- title
- More than one race
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 1
- group Id
- BG004
- value
- 1
- title
- Unknown or Not Reported
- denoms
- counts
- group Id
- BG000
- value
- 23
- group Id
- BG001
- value
- 67
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 89
- group Id
- BG004
- value
- 179
- units
- Participants
- title
- Initial Treatment
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 0
- title
- American Indian or Alaska Native
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 0
- title
- Asian
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 0
- title
- Native Hawaiian or Other Pacific Islander
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 2
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 2
- title
- Black or African American
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 9
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 9
- title
- White
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 0
- title
- More than one race
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 1
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 1
- title
- Unknown or Not Reported
- denoms
- counts
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 12
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 12
- units
- Participants
- title
- Retreatment
- param Type
- COUNT_OF_PARTICIPANTS
- population Description
- Cohort 3 patients had progressed following initial treatment in Cohorts 1, 2, 4 and then were retreated with a second TIL regimen. Data prior to initial TIL treatment are presented in the retreatment period for Cohort 3
- title
- Race (NIH/OMB)
- unit Of Measure
- Participants
- calculate Pct
- false
- classes
- categories
- measurements
- group Id
- BG000
- value
- 23
- group Id
- BG001
- value
- 56
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 55
- group Id
- BG004
- value
- 134
- denoms
- counts
- group Id
- BG000
- value
- 23
- group Id
- BG001
- value
- 67
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 89
- group Id
- BG004
- value
- 179
- units
- Participants
- title
- United States
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 2
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 1
- group Id
- BG004
- value
- 3
- denoms
- counts
- group Id
- BG000
- value
- 23
- group Id
- BG001
- value
- 67
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 89
- group Id
- BG004
- value
- 179
- units
- Participants
- title
- France
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 19
- group Id
- BG004
- value
- 19
- denoms
- counts
- group Id
- BG000
- value
- 23
- group Id
- BG001
- value
- 67
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 89
- group Id
- BG004
- value
- 179
- units
- Participants
- title
- Germany
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 2
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 2
- denoms
- counts
- group Id
- BG000
- value
- 23
- group Id
- BG001
- value
- 67
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 89
- group Id
- BG004
- value
- 179
- units
- Participants
- title
- Hungary
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 3
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 10
- group Id
- BG004
- value
- 13
- denoms
- counts
- group Id
- BG000
- value
- 23
- group Id
- BG001
- value
- 67
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 89
- group Id
- BG004
- value
- 179
- units
- Participants
- title
- Spain
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 1
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 1
- denoms
- counts
- group Id
- BG000
- value
- 23
- group Id
- BG001
- value
- 67
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 89
- group Id
- BG004
- value
- 179
- units
- Participants
- title
- Switzerland
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 3
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 4
- group Id
- BG004
- value
- 7
- denoms
- counts
- group Id
- BG000
- value
- 23
- group Id
- BG001
- value
- 67
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 89
- group Id
- BG004
- value
- 179
- units
- Participants
- title
- United Kingdom
- param Type
- COUNT_OF_PARTICIPANTS
- population Description
- Cohort 3 patients had progressed following initial treatment in Cohorts 1, 2, 4 and then were retreated with a second TIL regimen. Data prior to initial TIL treatment are presented in the retreatment period for Cohort 3
- title
- Region of Enrollment
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 8
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 8
- title
- United States
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 1
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 1
- title
- France
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 2
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 2
- title
- Germany
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 1
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 1
- title
- United Kingdom
- denoms
- counts
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 12
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 12
- units
- Participants
- description
- Region of enrollment for retreatment
- param Type
- COUNT_OF_PARTICIPANTS
- population Description
- This is the region of enrollment for retreatment
- title
- Region of Enrollment
- unit Of Measure
- Participants
- population Description
- The Safety Analysis Set is defined as patients who received the lifileucel infusion. Cohort 3 patients had progressed following initial treatment in Cohorts 1, 2, 4 and then were retreated with a second TIL regimen. Data are captured in the retreatment period for Cohort 3
Complete source fields
- denoms
- counts
- group Id
- BG000
- value
- 23
- group Id
- BG001
- value
- 67
- group Id
- BG002
- value
- 12
- group Id
- BG003
- value
- 89
- group Id
- BG004
- value
- 191
- units
- Participants
- groups
- description
- Non-cryopreserved LN-144 (Gen 1 infusion product) (Closed)
- id
- BG000
- title
- Cohort 1
- description
- Cryopreserved lifileucel (LN-144) (Gen 2 infusion product) (Closed)
- id
- BG001
- title
- Cohort 2
- description
- Retreatment cohort: patients from Cohort 1, Cohort 2 or Cohort 4 may rescreen for a second TIL regimen therapy if they meet all Inclusion and Exclusion Criteria (except exclusion criterion b) (Closed)
- id
- BG002
- title
- Cohort 3
- description
- Cryopreserved lifileucel (LN-144) (Gen 2 infusion product) (Closed)
- id
- BG003
- title
- Cohort 4
- description
- Total of all reporting groups
- id
- BG004
- title
- Total
- measures
- calculate Pct
- false
- classes
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 0
- title
- <=18 years
- measurements
- group Id
- BG000
- value
- 21
- group Id
- BG001
- value
- 53
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 66
- group Id
- BG004
- value
- 140
- title
- Between 18 and 65 years
- measurements
- group Id
- BG000
- value
- 2
- group Id
- BG001
- value
- 14
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 23
- group Id
- BG004
- value
- 39
- title
- >=65 years
- denoms
- counts
- group Id
- BG000
- value
- 23
- group Id
- BG001
- value
- 67
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 89
- group Id
- BG004
- value
- 179
- units
- Participants
- title
- Initial Treatment
- categories
- measurements
- group Id
- BG002
- value
- 0
- group Id
- BG004
- value
- 0
- title
- <=18 years
- measurements
- group Id
- BG002
- value
- 11
- group Id
- BG004
- value
- 11
- title
- Between 18 and 65 years
- measurements
- group Id
- BG002
- value
- 1
- group Id
- BG004
- value
- 1
- title
- >=65 years
- denoms
- counts
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 12
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 12
- units
- Participants
- title
- Retreatment
- param Type
- COUNT_OF_PARTICIPANTS
- population Description
- Cohort 3 patients had progressed following initial treatment in Cohorts 1, 2, 4 and then were retreated with a second TIL regimen. Data prior to initial TIL treatment are presented in the retreatment period for Cohort 3
- title
- Age, Categorical
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- lower Limit
- 37
- upper Limit
- 72
- value
- 52
- group Id
- BG001
- lower Limit
- 20
- upper Limit
- 79
- value
- 55
- group Id
- BG003
- lower Limit
- 25
- upper Limit
- 74
- value
- 58
- group Id
- BG004
- lower Limit
- 20
- upper Limit
- 79
- value
- 56
- denoms
- counts
- group Id
- BG000
- value
- 23
- group Id
- BG001
- value
- 67
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 89
- group Id
- BG004
- value
- 179
- units
- Participants
- title
- Initial Treatment
- categories
- measurements
- group Id
- BG002
- lower Limit
- 29
- upper Limit
- 66
- value
- 52
- group Id
- BG004
- lower Limit
- 29
- upper Limit
- 66
- value
- 52
- denoms
- counts
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 12
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 12
- units
- Participants
- title
- Retreatment
- dispersion Type
- FULL_RANGE
- param Type
- MEDIAN
- population Description
- Cohort 3 patients had progressed following initial treatment in Cohorts 1, 2, 4 and then were retreated with a second TIL regimen. Data prior to initial TIL treatment are presented in the retreatment period for Cohort 3
- title
- Age, Continuous
- unit Of Measure
- Years
- calculate Pct
- false
- classes
- categories
- measurements
- group Id
- BG000
- value
- 12
- group Id
- BG001
- value
- 28
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 44
- group Id
- BG004
- value
- 84
- title
- Female
- measurements
- group Id
- BG000
- value
- 11
- group Id
- BG001
- value
- 39
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 45
- group Id
- BG004
- value
- 95
- title
- Male
- denoms
- counts
- group Id
- BG000
- value
- 23
- group Id
- BG001
- value
- 67
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 89
- group Id
- BG004
- value
- 179
- units
- Participants
- title
- Initial Treatment
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 3
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 3
- title
- Female
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 9
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 9
- title
- Male
- denoms
- counts
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 12
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 12
- units
- Participants
- title
- Retreatment
- param Type
- COUNT_OF_PARTICIPANTS
- population Description
- Cohort 3 patients had progressed following initial treatment in Cohorts 1, 2, 4 and then were retreated with a second TIL regimen. Data prior to initial TIL treatment are presented in the retreatment period for Cohort 3
- title
- Sex: Female, Male
- unit Of Measure
- Participants
- calculate Pct
- false
- classes
- categories
- measurements
- group Id
- BG000
- value
- 2
- group Id
- BG001
- value
- 5
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 3
- group Id
- BG004
- value
- 10
- title
- Hispanic or Latino
- measurements
- group Id
- BG000
- value
- 21
- group Id
- BG001
- value
- 55
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 85
- group Id
- BG004
- value
- 161
- title
- Not Hispanic or Latino
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 7
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 1
- group Id
- BG004
- value
- 8
- title
- Unknown or Not Reported
- denoms
- counts
- group Id
- BG000
- value
- 23
- group Id
- BG001
- value
- 67
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 89
- group Id
- BG004
- value
- 179
- units
- Participants
- title
- Initial Treatment
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 1
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 1
- title
- Hispanic or Latino
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 10
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 10
- title
- Not Hispanic or Latino
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 1
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 1
- title
- Unknown or Not Reported
- denoms
- counts
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 12
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 12
- units
- Participants
- title
- Retreatment
- param Type
- COUNT_OF_PARTICIPANTS
- population Description
- Cohort 3 patients had progressed following initial treatment in Cohorts 1, 2, 4 and then were retreated with a second TIL regimen. Data prior to initial TIL treatment are presented in the retreatment period for Cohort 3
- title
- Ethnicity (NIH/OMB)
- unit Of Measure
- Participants
- calculate Pct
- false
- classes
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 0
- title
- American Indian or Alaska Native
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 2
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 1
- group Id
- BG004
- value
- 3
- title
- Asian
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 0
- title
- Native Hawaiian or Other Pacific Islander
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 1
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 2
- group Id
- BG004
- value
- 3
- title
- Black or African American
- measurements
- group Id
- BG000
- value
- 23
- group Id
- BG001
- value
- 64
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 85
- group Id
- BG004
- value
- 172
- title
- White
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 0
- title
- More than one race
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 1
- group Id
- BG004
- value
- 1
- title
- Unknown or Not Reported
- denoms
- counts
- group Id
- BG000
- value
- 23
- group Id
- BG001
- value
- 67
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 89
- group Id
- BG004
- value
- 179
- units
- Participants
- title
- Initial Treatment
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 0
- title
- American Indian or Alaska Native
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 0
- title
- Asian
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 0
- title
- Native Hawaiian or Other Pacific Islander
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 2
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 2
- title
- Black or African American
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 9
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 9
- title
- White
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 0
- title
- More than one race
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 1
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 1
- title
- Unknown or Not Reported
- denoms
- counts
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 12
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 12
- units
- Participants
- title
- Retreatment
- param Type
- COUNT_OF_PARTICIPANTS
- population Description
- Cohort 3 patients had progressed following initial treatment in Cohorts 1, 2, 4 and then were retreated with a second TIL regimen. Data prior to initial TIL treatment are presented in the retreatment period for Cohort 3
- title
- Race (NIH/OMB)
- unit Of Measure
- Participants
- calculate Pct
- false
- classes
- categories
- measurements
- group Id
- BG000
- value
- 23
- group Id
- BG001
- value
- 56
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 55
- group Id
- BG004
- value
- 134
- denoms
- counts
- group Id
- BG000
- value
- 23
- group Id
- BG001
- value
- 67
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 89
- group Id
- BG004
- value
- 179
- units
- Participants
- title
- United States
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 2
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 1
- group Id
- BG004
- value
- 3
- denoms
- counts
- group Id
- BG000
- value
- 23
- group Id
- BG001
- value
- 67
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 89
- group Id
- BG004
- value
- 179
- units
- Participants
- title
- France
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 19
- group Id
- BG004
- value
- 19
- denoms
- counts
- group Id
- BG000
- value
- 23
- group Id
- BG001
- value
- 67
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 89
- group Id
- BG004
- value
- 179
- units
- Participants
- title
- Germany
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 2
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 2
- denoms
- counts
- group Id
- BG000
- value
- 23
- group Id
- BG001
- value
- 67
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 89
- group Id
- BG004
- value
- 179
- units
- Participants
- title
- Hungary
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 3
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 10
- group Id
- BG004
- value
- 13
- denoms
- counts
- group Id
- BG000
- value
- 23
- group Id
- BG001
- value
- 67
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 89
- group Id
- BG004
- value
- 179
- units
- Participants
- title
- Spain
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 1
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 1
- denoms
- counts
- group Id
- BG000
- value
- 23
- group Id
- BG001
- value
- 67
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 89
- group Id
- BG004
- value
- 179
- units
- Participants
- title
- Switzerland
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 3
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 4
- group Id
- BG004
- value
- 7
- denoms
- counts
- group Id
- BG000
- value
- 23
- group Id
- BG001
- value
- 67
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 89
- group Id
- BG004
- value
- 179
- units
- Participants
- title
- United Kingdom
- param Type
- COUNT_OF_PARTICIPANTS
- population Description
- Cohort 3 patients had progressed following initial treatment in Cohorts 1, 2, 4 and then were retreated with a second TIL regimen. Data prior to initial TIL treatment are presented in the retreatment period for Cohort 3
- title
- Region of Enrollment
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 8
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 8
- title
- United States
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 1
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 1
- title
- France
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 2
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 2
- title
- Germany
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 1
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 1
- title
- United Kingdom
- denoms
- counts
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 12
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 12
- units
- Participants
- description
- Region of enrollment for retreatment
- param Type
- COUNT_OF_PARTICIPANTS
- population Description
- This is the region of enrollment for retreatment
- title
- Region of Enrollment
- unit Of Measure
- Participants
- population Description
- The Safety Analysis Set is defined as patients who received the lifileucel infusion. Cohort 3 patients had progressed following initial treatment in Cohorts 1, 2, 4 and then were retreated with a second TIL regimen. Data are captured in the retreatment period for Cohort 3
Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0
Preserved source evidence · Not medical advice
Triangle